Rita Kodida
YOU?
Author Swipe
View article: Opportunistic screening for broad range of medically relevant secondary findings: Laboratory benefits and burdens
Opportunistic screening for broad range of medically relevant secondary findings: Laboratory benefits and burdens Open
While the yield of reportable SFs was high, this was accompanied by many non-reportable VUS and increased efforts for exome analysis.
View article: P298: Decoding ambiguity: Evaluating the psychological harms and utility of returning cancer variants of uncertain significance
P298: Decoding ambiguity: Evaluating the psychological harms and utility of returning cancer variants of uncertain significance Open
View article: P686: Opportunistic screening for broad range of clinically relevant secondary findings: Outcomes of exome analysis in the Incidental Genomics RCT
P686: Opportunistic screening for broad range of clinically relevant secondary findings: Outcomes of exome analysis in the Incidental Genomics RCT Open
View article: P609: Mainstreaming genetics: Evaluation of a digital application to scale and spread oncologist-initiated genetic testing
P609: Mainstreaming genetics: Evaluation of a digital application to scale and spread oncologist-initiated genetic testing Open
View article: Genetics Navigator: protocol for a mixed methods randomized controlled trial evaluating a digital platform to deliver genomic services in Canadian pediatric and adult populations
Genetics Navigator: protocol for a mixed methods randomized controlled trial evaluating a digital platform to deliver genomic services in Canadian pediatric and adult populations Open
Introduction Genetic testing is used across medical disciplines leading to unprecedented demand for genetic services. This has resulted in excessive waitlists and unsustainable pressure on the standard model of genetic healthcare. Alternat…
View article: Genetics Adviser: The development and usability testing of a new patient digital health application to support clinical genomic testing
Genetics Adviser: The development and usability testing of a new patient digital health application to support clinical genomic testing Open
View article: P523: Returning all clinically relevant findings from genomic sequencing: Preliminary results from the incidental genomics RCT
P523: Returning all clinically relevant findings from genomic sequencing: Preliminary results from the incidental genomics RCT Open
While guidelines prioritize the return of medically actionable secondary findings (SFs) from genomic sequencing (GS), practice is shifting toward returning a broader range of results to patients and research participants, including variant…
View article: P538: Curious but cautious: Patients’ preferences for all types of clinically actionable genomic incidental results
P538: Curious but cautious: Patients’ preferences for all types of clinically actionable genomic incidental results Open
Genomic sequencing (GS) can generate a large volume of incidental results (IR), findings that are unrelated to the primary indication, but which can have varying levels of medical actionability. Guidelines (eg, ACMG) recommend that patient…
View article: P555: Clinical utility returning of all types of medically relevant genomic sequencing findings: An observational study
P555: Clinical utility returning of all types of medically relevant genomic sequencing findings: An observational study Open
Guidelines prioritize medically actionable secondary findings (SFs), but a broader spectrum of clinically relevant results could be analyzed and returned. However, evidence on the clinical outcomes of returning results beyond medically act…
View article: P516: The Genetics Navigator: The development and usability testing of a new patient-facing digital health application to support clinical genetic testing
P516: The Genetics Navigator: The development and usability testing of a new patient-facing digital health application to support clinical genetic testing Open
Strategies for improving the capacity and efficiency of genetic service delivery are vital in supporting genetic healthcare providers while maintaining patient satisfaction. Patient-facing digital tools, which support clinicians in scaling…
View article: “I don’t need any more unknowns hanging over my head”: Views of patients with cancer on variants of uncertain significance and low/moderate risk results from genomic sequencing
“I don’t need any more unknowns hanging over my head”: Views of patients with cancer on variants of uncertain significance and low/moderate risk results from genomic sequencing Open
View article: Finding the sweet spot: a qualitative study exploring patients’ acceptability of chatbots in genetic service delivery
Finding the sweet spot: a qualitative study exploring patients’ acceptability of chatbots in genetic service delivery Open
View article: P409: Clinical utility of genomic sequencing for hereditary cancer syndromes: An observational chart review
P409: Clinical utility of genomic sequencing for hereditary cancer syndromes: An observational chart review Open
View article: P543: Comparing the analytical performance of exome sequencing and traditional panel testing in a cancer population
P543: Comparing the analytical performance of exome sequencing and traditional panel testing in a cancer population Open
View article: A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findings
A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findings Open
Genomic sequencing (GS) can reveal secondary findings (SFs), findings unrelated to the reason for testing, that can be overwhelming to both patients and providers. An effective approach for communicating all clinically significant primary …
View article: Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery
Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery Open
Introduction The high demand for genetic tests and limited supply of genetics professionals has created a need for alternative service delivery models. Digital tools are increasingly being used to support multiple points in the genetic tes…
View article: eP299: Genetics adviser: The development and usability testing of a new patient-centered digital health application to support clinical genomic testing
eP299: Genetics adviser: The development and usability testing of a new patient-centered digital health application to support clinical genomic testing Open
View article: eP392: A comprehensive genomic test reporting structure for communicating cancer and incidental findings
eP392: A comprehensive genomic test reporting structure for communicating cancer and incidental findings Open
View article: Widening the lens of actionability: A qualitative study of primary care providers’ views and experiences of managing secondary genomic findings
Widening the lens of actionability: A qualitative study of primary care providers’ views and experiences of managing secondary genomic findings Open
View article: The role of digital tools in the delivery of genomic medicine: enhancing patient-centered care
The role of digital tools in the delivery of genomic medicine: enhancing patient-centered care Open
View article: Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort study
Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort study Open
Background Exome and genome sequencing have been demonstrated to increase diagnostic yield in paediatric populations, improving treatment options and providing risk information for relatives. There are limited studies examining the clinica…
View article: Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial
Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial Open
Introduction Genomic sequencing has rapidly transitioned into clinical practice, improving diagnosis and treatment options for patients with hereditary disorders. However, large-scale implementation of genomic sequencing faces challenges, …